This is not the most recent version of the article. View current version (21 MAY 2015)

Intervention Protocol

Complete decongestive therapy for lymphedema following breast cancer treatment

  1. Doris M Howell1,*,
  2. Jeanette Ezzo2,
  3. Linda Bily3,
  4. Karin Johansson4

Editorial Group: Cochrane Breast Cancer Group

Published Online: 21 JAN 2002

DOI: 10.1002/14651858.CD003475


How to Cite

Howell DM, Ezzo J, Bily L, Johansson K. Complete decongestive therapy for lymphedema following breast cancer treatment (Protocol). Cochrane Database of Systematic Reviews 2002, Issue 1. Art. No.: CD003475. DOI: 10.1002/14651858.CD003475.

Author Information

  1. 1

    Princess Margaret Hospital, Lymphoedema, Toronto, Ontario, Canada

  2. 2

    James P. Swyers Enterprises, Research, Baltimore, Maryland, USA

  3. 3

    New York, New York, USA

  4. 4

    Lund University Hospital, Lymphoedema Unit, Lund, Sweden

*Doris M Howell, Lymphoedema, Princess Margaret Hospital, 610 University Ave (Ste. 15-617), Toronto, Ontario, M5G2M9, Canada. doris.howell@uhn.on.ca.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2002

SEARCH

This is not the most recent version of the article. View current version (21 MAY 2015)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The primary objective of this review is to assess the effects of complete decongestive physiotherapy or manual lymphatic drainage alone on the primary outcome of arm volume reduction or the secondary outcomes of chest wall volume reduction, functional improvement, and pain reduction for women with secondary lymphedema as a result of treatment of breast cancer.